"Hope Center for Blood Disease and Cancer Care, providing cancer and blood disease care"

During the past decade, RHHP/Hope Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "RHHP/Hope Cancer Center" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "Cephalon" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "RHHP/Hope Cancer Center" are "Diffuse Large B-Cell Lymphoma" (1 trials), "Mantle Cell Lymphoma" (1 trials), "Metastatic Breast Cancer" (1 trials), "Multiple Myeloma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "RHHP/Hope Cancer Center" in a lesser frequency.

Most popular intervention types in "RHHP/Hope Cancer Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (1 trials), "Bortezomib" (1 trials), "Docetaxel/Carboplatin" (1 trials), "Docetaxel/Carboplatin/Bevacizumab/Erlotinib" (1 trials) and "Ixabepilone" (1 trials). Other intervention names were less common.

The vast majority of trials in "RHHP/Hope Cancer Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "RHHP/Hope Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in RHHP/Hope Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RHHP/Hope Cancer Center, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".